A Randomized, Single-Blind, Crossover Study in Healthy Volunteers to Demonstrate the Bioequivalence of Interferon Beta-1a Manufactured by Two Different Processes.
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2015
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Glioma; Hepatitis B; Hepatitis C; Human papillomavirus infections; Multiple sclerosis
- Focus Pharmacokinetics
- Sponsors Biogen Idec
- 07 Jun 2017 Biomarkers information updated
- 12 Apr 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
- 12 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.